Author: Eli Lilly and Company

News

Foundayo™ (orforglipron), Lilly’s new orally administered GLP-1 pill for weight loss, is now available in the United States.

April 15, 2026
Eli Lilly and Company
No Comments

Foundayo is now available through LillyDirect® and telemedicine providers, and is being distributed to all retail…